共 50 条
- [3] Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry Arthritis Research & Therapy, 25
- [8] The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs Arthritis Research & Therapy, 19